Literature DB >> 7175440

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.

A N Houghton, M Eisinger, A P Albino, J G Cairncross, L J Old.   

Abstract

The surface antigens of melanocytes from newborn and adult skin have been analyzed with monoclonal antibodies detecting cell surface antigens of malignant melanoma. Antigenic markers that distinguish early, intermediate, and mature stages in melanocyte differentiation have been defined. The characteristics of the normal melanocyte precursor have been inferred from the features of melanomas that express early markers of melanocyte differentiation. A rudimentary surface antigen map of cells undergoing melanocyte differentiation and a new classification of melanomas based on the expression of melanocyte differentiation antigens are proposed.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7175440      PMCID： PMC2186870          DOI： 10.1084/jem.156.6.1755

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  17 in total

1.  Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse.

Authors:  E A Boyse; M Miyazawa; T Aoki; L J Old
Journal:  Proc R Soc Lond B Biol Sci       Date:  1968-06-11

2.  The tyrosine hydroxylase activity of mammalian tyrosinase.

Authors:  S H Pomerantz
Journal:  J Biol Chem       Date:  1966-01-10       Impact factor: 5.157

3.  Common human melanoma-associated antigen(s) detected by monoclonal antibodies.

Authors:  S Carrel; R S Accolla; A L Carmagnola; J P Mach
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

4.  Serological analysis of cell surface antigens of malignant human brain tumors.

Authors:  M Pfreundschuh; H Shiku; T Takahashi; R Ueda; J Ransohoff; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Cell surface antigens of human melanoma identified by monoclonal antibody.

Authors:  M Y Yeh; I Hellström; J P Brown; G A Warner; J A Hansen; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  Study of antibodies against human melanoma produced by somatic cell hybrids.

Authors:  H Koprowski; Z Steplewski; D Herlyn; M Herlyn
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

7.  Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.

Authors:  K O Lloyd; J Ng; W G Dippold
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

8.  Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

Authors:  T E Carey; T Takahashi; L A Resnick; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

9.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.

Authors:  W G Dippold; K O Lloyd; L T Li; H Ikeda; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.

Authors:  A N Houghton; M C Taormina; H Ikeda; T Watanabe; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205
View more
  78 in total

1.  Changes in protein expression during melanoma differentiation determined by computer analysis of 2-D gels.

Authors:  D Easty; I R Hart; K Patel; C Seymour; M Yacoub; A Domscheit; S Gunther; W Postel; A Gorg; M J Dunn
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

2.  In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity.

Authors:  J H Xiang; A K Kimura
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

3.  Cell adhesion to anosmin via α5β1, α4β1, and α9β1 integrins.

Authors:  Yukinori Endo; Hiroko Ishiwata-Endo; Kenneth M Yamada
Journal:  Cell Adh Migr       Date:  2018-02-20       Impact factor: 3.405

4.  Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.

Authors:  P Garin-Chesa; H R Beresford; A Carrato-Mena; H F Oettgen; L J Old; M R Melamed; W J Rettig
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  A distinct octamer-binding protein present in malignant melanoma cells.

Authors:  P M Cox; S M Temperley; H Kumar; C R Goding
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

6.  Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.

Authors:  R V Lloyd; T L Johnson; M Blaivas; J C Sisson; B S Wilson
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

7.  Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.

Authors:  V Feyles; W T Dixon; L K Sikora; R C McGarry; L M Jerry
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

8.  Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.

Authors:  Francesca Avogadri; Taha Merghoub; Maureen F Maughan; Daniel Hirschhorn-Cymerman; John Morris; Erika Ritter; Robert Olmsted; Alan N Houghton; Jedd D Wolchok
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

9.  Expression of different immunological markers by cultured human melanocytes.

Authors:  N Smit; I Le Poole; R van den Wijngaard; A Tigges; W Westerhof; P Das
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  Functional neurons and melanocytes induced from immortal lines of postnatal neural crest-like stem cells.

Authors:  Elena V Sviderskaya; David J Easty; Mark A Lawrence; Daniel P Sánchez; Yuri A Negulyaev; Ricken H Patel; Praveen Anand; Yuri E Korchev; Dorothy C Bennett
Journal:  FASEB J       Date:  2009-05-15       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.